| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 36.81B | 36.25B | 36.91B | 36.58B | 36.01B | 33.89B |
| Gross Profit | 9.20B | 9.53B | 9.25B | 9.50B | 8.69B | 8.65B |
| EBITDA | 5.73B | 5.30B | 5.76B | 5.52B | 4.35B | 4.36B |
| Net Income | 2.50B | 2.98B | 2.57B | 2.60B | 2.25B | 2.34B |
Balance Sheet | ||||||
| Total Assets | 55.35B | 57.67B | 53.01B | 55.15B | 51.23B | 50.08B |
| Cash, Cash Equivalents and Short-Term Investments | 5.73B | 3.99B | 4.95B | 2.92B | 3.97B | 3.77B |
| Total Debt | 3.41B | 4.63B | 1.28B | 2.01B | 3.06B | 4.38B |
| Total Liabilities | 18.25B | 17.88B | 15.53B | 18.37B | 18.05B | 19.17B |
| Stockholders Equity | 37.09B | 39.79B | 37.48B | 36.77B | 33.18B | 30.90B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -2.93B | 1.29B | 377.00M | 989.00M | 2.02B |
| Operating Cash Flow | 0.00 | 1.87B | 4.70B | 2.15B | 2.06B | 3.06B |
| Investing Cash Flow | 0.00 | -3.74B | -991.00M | -1.37B | -65.00M | -984.00M |
| Financing Cash Flow | 0.00 | 942.00M | -1.70B | -1.84B | -1.78B | -3.98B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥52.46B | 25.62 | 9.07% | 4.46% | 3.09% | 22.56% | |
70 Outperform | ¥84.99B | 10.06 | ― | 3.74% | 0.53% | 30.98% | |
69 Neutral | ¥53.06B | -711.15 | ― | 4.32% | -19.49% | -101.29% | |
63 Neutral | ¥299.61B | 20.15 | 9.45% | 2.65% | 1.87% | -5.06% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
56 Neutral | ¥47.89B | 19.07 | ― | 1.92% | -1.81% | 20.12% | |
56 Neutral | ¥331.00B | 32.98 | 6.95% | 3.06% | -6.88% | ― |